Mark J. Tarr's stock holdings in Encompass Health have seen significant changes, reflecting his strong tie to the company's performance. In late 2019, his holdings were valued at approximately $21.51 million, steadily increasing to around $34.91 million by August 2023....

Mark J. Tarr's stock holdings in Encompass Health have seen significant changes, reflecting his strong tie to the company's performance. In late 2019, his holdings were valued at approximately $21.51 million, steadily increasing to around $34.91 million by August 2023. This growth continued, with his holdings peaking in March 2024 at approximately $51.32 million. His wealth is heavily tied to the company's stock, illustrating the alignment of his interests with those of shareholders and the focus on enhancing long-term value. The fluctuation in value also highlights the impact of market conditions on executive wealth, showcasing the risks and rewards associated with substantial equity ownership in his role as CEO.